opioids Archive — Page 3 of 7
-
May 18, 2020
Women in criminal justice system less likely to receive evidence-based treatment for opioid use disorder
Pregnant women involved in the criminal justice system are disproportionately not receiving medications for opioid use disorder, as compared to their peers, according to a Vanderbilt-led study published today in PLOS Medicine. -
May 12, 2020
Study finds newborn opioid withdrawal rates show evidence of stabilizing
Rates of neonatal abstinence syndrome (NAS) have plateaued after 20 years of increasing frequency across the country, according to a new study published in Health Affairs. NAS is a withdrawal syndrome experienced by some opioid-exposed newborns after birth. -
April 22, 2020
Safeguarding opioids a concern as children may have more access with families at home due to COVID-19
A new poll from the Vanderbilt Center for Child Health Policy found that few Tennessee parents take steps to safeguard opioids at home, an important concern when children are spending more time indoors due to COVID-19 social distancing recommendations. -
February 24, 2020
Reducing postoperative opioids
An opioid-restrictive prescribing protocol reduced the number of postoperative opioid prescriptions and the oral morphine equivalent per prescription. -
December 20, 2019
Tennessee Receives Grant from Federal Government to Address Opioid Crisis
The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants. -
December 12, 2019
New training materials help clinicians stay opioid compliant
Vanderbilt University Medical Center, through the offices of its Opioid Oversight Executive Committee, is offering its employees an online tutorial, Opioid Laws — Prescribing at VUMC -
December 5, 2019
Multisite study focuses on opioid use during pregnancy
The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.